BioCorRx (BICX) Asset Writedowns and Impairment (2015 - 2023)

BioCorRx (BICX) posted Asset Writedowns and Impairment of $47980.0 for Q1 2023, up 1311.18% sequentially from $3400.0 in Q2 2019.

BioCorRx (BICX) Asset Writedowns and Impairment (2015 - 2023) Analysis & Trends

BioCorRx has reported Asset Writedowns and Impairment for 6 years, with the latest figure at $47980.0 in Q1 2023.

Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $47980.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $47980.0 (changed N/A YoY) and the FY2023 annual result came in at $47980.0, changed N/A from the prior year.
Asset Writedowns and Impairment improved to $47980.0 in Q1 2023 per BICX's latest filing, from $3400.0 in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $47980.0 in Q1 2023 and troughed at -$1000.0 in Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	88.19 Bn	90.61 Bn	15.19 Bn
2	Tenet Healthcare	21.59 Bn	21.56 Bn	4.45 Bn
3	Encompass Health	12.19 Bn	12.86 Bn	1.34 Bn
4	Davita	11.52 Bn	12.39 Bn	1.16 Bn
5	Ensign	10.59 Bn	10.27 Bn	306.24 Mn
6	Universal Health Services	8.79 Bn	8.72 Bn	3.29 Bn
7	Pacs	7.04 Bn	6.88 Bn	338.46 Mn
8	Chemed	6.96 Bn	6.92 Bn	221.47 Mn
9	Concentra Group Holdings Parent	4.52 Bn	4.38 Bn	192.10 Mn
10	BioCorRx	1.49 Mn	1.47 Mn	-

Download Data